Published in J Immunol on January 01, 1976
Antigenic heterogeneity of the non-serogroup antigen structure of Neisseria gonorrhoeae lipopolysaccharides. Infect Immun (1979) 1.83
Immunological responses of mice to lipopolysaccharide: lack of secondary responsiveness by C3H/HeJ mice. Infect Immun (1977) 1.09
Effect of lipid A-associated protein and lipid A on the expression of lipopolysaccharide activity. I. Immunological activity. Immunology (1980) 1.03
Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen. J Exp Med (1983) 0.99
Dissociation of the anti-hapten and anti-carrier responses of mice injected with dinitrophenylated lipopolysaccharide. Infect Immun (1981) 0.86
Deficient antibody formation in the bone marrow of nude mice. Immunology (1978) 0.85
Protection of mice against the lethal toxicity of a lipopolysaccharide (LPS) by immunization with anti-idiotype antibody to a monoclonal antibody to lipid A from Eikenella corrodens LPS. Infect Immun (1990) 0.83
Depression of the antibody response in Pseudomonas aeruginosa-injected mice. Infect Immun (1979) 0.81
Characterization of Chemically-Induced Bacterial Ghosts (BGs) Using Sodium Hydroxide-Induced Vibrio parahaemolyticus Ghosts (VPGs). Int J Mol Sci (2016) 0.75
A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges. PLoS One (2017) 0.75
Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86
Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30
Physical aspects of reversible inactivation of endotoxin. Ann N Y Acad Sci (1966) 2.21
Molecular immunogenicity of bacterial lipopolysaccharide antigens: establishing a quantitative system. J Immunol (1971) 1.75
Frequency of occurrence of native hapten among enterobacterial species. J Bacteriol (1966) 1.66
Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bacteriol (1969) 1.48
Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res (1979) 1.44
Physical structure of a native protoplasmic polysaccharide from Escherichia coli. J Immunol (1967) 1.32
Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Infect Immun (1988) 1.31
Hybrid formation between bacterial endotoxins. J Exp Med (1967) 1.26
Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res (2000) 1.22
Alteration and restoration of endotoxin activity after complexing with plasma proteins. J Bacteriol (1966) 1.19
Immunological responses of mice to native protoplasmic polysaccharide and lipopolysaccharide: functional separation of the two signals required to stimulate a secondary antibody response. J Exp Med (1974) 1.17
Modification of selected host-reactive properties of endotoxin by treatment with sodium deoxycholate. J Bacteriol (1968) 1.12
Endotoxin-cell-membrane interactions leading to transmembrane signaling. Contemp Top Mol Immunol (1981) 1.11
Immunological responses of mice to lipopolysaccharide: lack of secondary responsiveness by C3H/HeJ mice. Infect Immun (1977) 1.09
Ability of monophosphoryl lipid A to augment the antibody response of young mice. Infect Immun (1988) 1.09
Modulation of the immune response to lipopolysaccharide. J Immunol (1982) 1.04
Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med (1995) 1.03
Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice. Infect Immun (1989) 1.00
Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen. J Exp Med (1983) 0.99
Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigens. Infect Immun (1984) 0.91
Structural and functional heterogeneity of Fc receptors. Cold Spring Harb Symp Quant Biol (1977) 0.91
Reaction of endotoxin and surfactants. II. Immunologic properties of endotoxins treated with sodium deoxycholate. J Immunol (1968) 0.91
Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. J Immunol (1991) 0.91
Cyclic development of immunological memory to bacterial lipopolysaccharide. Infect Immun (1985) 0.91
Potentiation of endotoxicity by carrageenan. Infect Immun (1978) 0.90
Dissociation of the anti-hapten and anti-carrier responses of mice injected with dinitrophenylated lipopolysaccharide. Infect Immun (1981) 0.86
Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun (1993) 0.86
Cellular responses to bacterial lipopolysaccharide: T cells recognize LPS determinants. Scand J Immunol (1983) 0.86
Antigenic competition between and endotoxic adjuvant and a protein antigen. Infect Immun (1971) 0.86
Reaction of endotoxin and surfactants. 3. Effect of sodium lauryl sulfate on the structure and pyrogenicity of endotoxin. Can J Microbiol (1968) 0.85
Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide. Infect Immun (1989) 0.83
Inactivation of endotoxin by serum: a phylogenetic study. J Infect Dis (1974) 0.83
Increased activation of antigen-primed or memory B cells by bacterial lipopolysaccharide. Cell Immunol (1987) 0.82
Endotoxin-altering activity in serum of developing chicken embryo: lack of correlation with embryonic susceptibility to injected endotoxin. Infect Immun (1973) 0.82
Study of the idiotypy of lipopolysaccharide-specific polyclonal and monoclonal antibodies. Eur J Immunol (1982) 0.81
A quantitative estimation of sodium deoxycholate remaining in reassociated, hybrid endotoxins. Proc Soc Exp Biol Med (1971) 0.81
Some requisites in systems leading to hybrid formation between bacterial endotoxins. J Infect Dis (1970) 0.80
Immunological investigations of Penicillium. II. Primary binding of glycopeptides and glycopeptide derivatives to specific antibodies. Immunochemistry (1973) 0.80
Interim results of a phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (theraccine) in the treatment of disseminated malignant melanoma. Semin Surg Oncol (1993) 0.80
Radioimmunoassay for quantifying antibody to N. Gonorrhoeae in human sera. Br J Vener Dis (1975) 0.80
Immunologic responses of mice to lipopolysaccharide from Escherichia coli. J Infect Dis (1973) 0.79
Reference endotoxin: a practical rationale. Prog Clin Biol Res (1982) 0.79
RIIIS/J mice lack a gene influencing the capacity to make an antibody response to helper T cell-independent antigens. J Immunol (1982) 0.78
Contributions to the ecology of Colorado tick fever virus. 2. Population dynamics and host utilization of immature stages of the Rocky Mountain wood tick, Dermacentor andersoni. J Med Entomol (1976) 0.77
Cellular responses to bacterial lipopolysaccharide: LPS facilitates priming of antigen-reactive T cells. Scand J Immunol (1983) 0.76
Occult endotoxin in bacterial protoplasm. J Bacteriol (1969) 0.75
The use of glycogen-induced guinea pig polymorphonuclear leukocytes to detect inhibitors of chemotaxis found in human serum. Diagn Immunol (1985) 0.75
A potential surrogate marker of efficacy for a therapeutic melanoma vaccine. Ann N Y Acad Sci (1993) 0.75
Pseudosecondary antibody response to LPS induced by toxins for macrophages. J Reticuloendothel Soc (1982) 0.75